World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
114
Citations
45828
World Ranking
4762
National Ranking
181

Research.com Recognitions

  • 2021 - Member of the Royal Netherlands Academy of Arts and Sciences
  • 2019 - Doctor Honoris Causa, Semmelweis University
  • 2019 - Member of Academia Europaea

Overview

Pancras C.W. Hogendoorn is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily spans the field of Medicine, with a focused concentration on several subfields including Pulmonary and Respiratory Medicine, Rheumatology, Oncology, Infectious Diseases, and the History of Medicine. The scope of research topics features Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Histiocytic Disorders and Treatments, Medical History and Innovations, History of Medicine Studies, Bone Health and Treatments, and Lymphoma Diagnosis and Treatment.

Recent publications demonstrate a variety of interests across clinical and pathological studies. Notable papers include:

  • ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition (2021) published in Blood
  • Immunological factors linked to geographical variation in vaccine responses (2023) published in Nature reviews. Immunology
  • Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation (2020) published in The Journal of Pathology Clinical Research
  • Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports (2021) published in PubMed
  • Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB): Analysis of 21 cases (2021) published in Annals of Diagnostic Pathology

Frequent collaborators in their research include I. F. Hendriks, F. Boer, Paul G. Kemps, Judith V.M.G. Bovée, and Robert M. Verdijk, each contributing to multiple joint publications.

Their work has appeared in a variety of publication venues where they have consistently contributed, including:

  • Vestnik of Saint Petersburg University Medicine
  • Cancers
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Journal of Anatomy and Histopathology
  • Blood

In recognition of their academic contributions, they were awarded membership in the Academia Europaea in 2019.

Best Publications

  • Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial*

    Jaap Verweij;Paolo G. Casali;John Zalcberg;Axel LeCesne

  • Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

    Ian Judson;Jaap Verweij;Hans Gelderblom;Jörg T Hartmann;Jörg T Hartmann

  • Consensus meeting for the management of gastrointestinal stromal tumors Report of the GIST Consensus Conference of 20–21 March 2004, under the auspices of ESMO

    Jean Yves Blay;Sylvie Bonvalot;Paolo Casali;Haesun Choi

  • IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

    M. Fernanda Amary;Krisztian Bacsi;Francesca Maggiani;Stephen Damato

  • Sarcoma derived from cultured mesenchymal stem cells

    Jakub Tolar;Alma J. Nauta;Mark J. Osborn;Angela Panoskaltsis Mortari

  • The Clinical Approach Towards Chondrosarcoma

    Hans Gelderblom;Pancras C.W. Hogendoorn;Sander D. Dijkstra;Carla S. van Rijswijk

  • Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

    Isabelle Ray-Coquard;Claire Cropet;Martine Van Glabbeke;Catherine Sebban

  • Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    P.G. Casali;J.-Y. Blay

  • Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Neyssa M Marina;Sigbjørn Smeland;Stefan S Bielack;Mark Bernstein

  • Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial

    Penella J. Woll;Peter Reichardt;Axel Le Cesne;Sylvie Bonvalot

  • Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Sigbjørn Smeland;Stefan S. Bielack;Jeremy Whelan;Mark Bernstein

  • Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

    Jakob K. Anninga;Hans Gelderblom;Marta Fiocco;Judith R. Kroep

  • Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Stefan S. Bielack;Sigbjørn Smeland;Jeremy S. Whelan;Neyssa Marina

  • Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

    Emilie P. Buddingh;Marieke L. Kuijjer;Ronald A J Duim;Horst Bürger

  • Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup

    Ian J. Lewis;Marianne A. Nooij;Jeremy Whelan;Matthew R. Sydes

  • Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study.

    Wim G. Goettsch;Steffan D. Bos;Nancy Breekveldt-Postma;Mariel Casparie

  • The histopathological differential diagnosis of gastrointestinal stromal tumours.

    J F Graadt van Roggen;M L F van Velthuysen;P C W Hogendoorn

  • Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study.

    Martine Van Glabbeke;Jaap Verweij;Paolo G Casali;Axel Le Cesne

  • Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples.

    Danielle M. de Jong;Sofie Lj Verbeke;Danielle Meijer;Pancras Cw Hogendoorn

  • EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

    J. S. Whelan;S. S. Bielack;N. Marina;S. Smeland

Frequent Co-Authors

Judith V.M.G. Bovée
Judith V.M.G. Bovée Leiden University Medical Center
Karoly Szuhai
Karoly Szuhai Leiden University Medical Center
Hans Gelderblom
Hans Gelderblom Leiden University Medical Center
Cees J. Cornelisse
Cees J. Cornelisse Leiden University Medical Center
Adrienne M. Flanagan
Adrienne M. Flanagan University College London
Matthew R. Sydes
Matthew R. Sydes University College London
Nicholas A. Athanasou
Nicholas A. Athanasou University of Oxford
Arjan C. Lankester
Arjan C. Lankester Leiden University Medical Center
Jaap Verweij
Jaap Verweij Erasmus University Rotterdam
Peter Hohenberger
Peter Hohenberger Heidelberg University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine in the USA offers a variety of online educational paths that can complement or provide alternatives to traditional MD programs. For nurses aiming to advance their qualifications, consider exploring the cheapest bsn to dnp programs. These allow registered nurses to earn a Doctor of Nursing Practice (DNP) degree online with affordable tuition options.

Pharmacists or pharmacy students may be interested in pursuing advanced credentials through pharm d online programs. These programs offer flexibility for working professionals seeking to expand their career prospects in pharmaceutical care and management.

For those drawn toward healthcare technology and administration, obtaining RHIA certification can open doors. Accredited rhia certification programs online prepare graduates for in-demand roles managing patient data and ensuring health information security.

Finally, if you are considering support roles in healthcare, medical billing and coding is a highly sought-after skillset. Learn about tuition and program options by researching how much is medical billing and coding school before you enroll.

Best Scientists Citing Pancras C.W. Hogendoorn

Trending Scientists

Recently Published Articles